WebGet access to cutting edge treatment via IN Placebo, IM Placebo, BPL-1357. View duration, location, compensation, and staffing details. All > Influenza. BPL-1357 for Influenza. Phase-Based Progress Estimates. 1. Effectiveness. 1. Safety. National Institutes of Health Clinical Center, Bethesda, MD Influenza BPL-1357 - Biological. WebBiological/Vaccine: BPL-1357 Other: IM Placebo Other: IN Placebo. Supporting Site. National Institute of Allergy and Infectious Diseases. Background: Influenza (flu) is a virus that infects people of all ages. Some people may have mild flu symptoms. Others may get very sick and even die from the flu. Flu vaccines help protect people against the ...
Potential Universal Flu Vaccine Trial Worldhealth.net Anti-Aging …
WebJul 8, 2024 · The vaccine: BPL-1357 was developed by National Institute of Allergy and Infectious Diseases (NIAID) researchers. The vaccine is a “whole virus” vaccine, bundling together four strains of low-risk avian influenza viruses that have been killed, similar to … WebBPL-1357 Study Objectives 2 Primary · 29 Secondary · Reporting Duration: Up to 3 years Baseline to 3 years Change from Baseline in Frailty Index Up to 3 years Antibody Titers to Genetically Detoxified Form of Exotoxin A Derived from Pseudomonas Aeruginosa (EPA) as Determined by Multiplex ECL-based Immunoassay celebrating white history month
Top 10 Flu Clinical Trials [2024 Studies] Power
WebRandomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine Researchers at the National Institutes of Health (NIH) are studying a new influenza (flu) … WebNov 9, 2024 · Researchers are in the process of enrolling subjects for a Phase I trial. The strains included in BPL-1357 are not infectious in humans, but researchers hope that the whole-virus vaccine approach will mimic the immunity gained from natural infection, including mucosal immunity. WebJul 13, 2024 · BPL-1357 is a whole-virus vaccine consisting of four strains of noninfectious, chemically inactivated, low-pathogenicity avian flu virus. Volunteers will return to the clinic seven times to... celebrating women in chemistry